Harvard Bioscience Stock Price and Value Analysis

Should you buy Harvard Bioscience stock? (NasdaqGM:HBIO). Let's see how it does in our automated value investing analysis system.

  • This company is solid.
  • This company is making money at a modest rate.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

HBIO Free Cash Flow Trend

Based on historical returns, we believe that Harvard Bioscience can grow its free cash at a rate of about 4%. That's positive!

Free Cash Flow trendline for HBIO
Free Cash Flow trendline for Harvard Bioscience

Inside the HBIO Numbers

HBIO Price
(Harvard Bioscience stock price per share)
[?] HBIO Fair Price
(based on intrinsic value)
[?] HBIO Safety Price (based on a variable margin of safety) $1.89
[?] PE Ratio versus Sector 3121% higher than other Healthcare stocks
[?] PE Ratio versus Industry 2608% higher than other Medical Instruments & Supplies stocks
[?] Cash Yield 3.76%
[?] Free Cash Flow Jitter 174%

Is Harvard Bioscience Stock on Sale?

We believe that Harvard Bioscience may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Harvard Bioscience looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy HBIO Stock?

Does Harvard Bioscience have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.